859
+0.47%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥27.06bn
FY2017FY2026
Net income
¥1.89bn
FY2017FY2026
Free cash flow
¥6.21bn
FY2017FY2026
Shareholders' equity
¥13.98bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥27.06bn | ¥22.26bn | ¥20.77bn | ¥21.25bn | ¥18.89bn | ¥17.01bn | ¥17.97bn | ¥17.41bn | ¥16.81bn | ¥14.81bn |
| Gross profit | ¥7.29bn | ¥6.79bn | ¥6.35bn | ¥6.00bn | ¥5.33bn | ¥4.96bn | ¥5.95bn | ¥5.76bn | ¥5.34bn | ¥4.90bn |
| Operating income | ¥2.94bn | ¥2.52bn | ¥2.29bn | ¥2.08bn | ¥1.78bn | ¥1.50bn | ¥2.26bn | ¥2.03bn | ¥1.77bn | ¥1.63bn |
| Net income | ¥1.89bn | ¥1.60bn | ¥1.48bn | ¥1.38bn | ¥1.11bn | ¥952.5m | ¥1.20bn | ¥1.25bn | ¥1.09bn | ¥1.01bn |
| Diluted earnings per share | 110.57 | 90.76 | 84.21 | 78.41 | 61.45 | 52.92 | 66.68 | 69.45 | 60.44 | 56.29 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥28.14bn | ¥30.89bn | ¥28.82bn | ¥27.24bn | ¥26.53bn | ¥25.25bn | ¥27.13bn | ¥25.69bn | ¥23.06bn | ¥18.69bn |
| Cash and short-term investments | ¥9.20bn | ¥8.30bn | ¥6.80bn | ¥5.86bn | ¥5.93bn | ¥5.16bn | ¥5.97bn | ¥6.39bn | ¥6.10bn | ¥4.82bn |
| Total liabilities | ¥13.90bn | ¥17.55bn | ¥16.56bn | ¥16.00bn | ¥15.89bn | ¥15.23bn | ¥17.57bn | ¥16.84bn | ¥15.09bn | ¥11.53bn |
| Debt | ¥9.10bn | ¥13.13bn | ¥12.51bn | ¥11.91bn | ¥12.05bn | ¥12.11bn | ¥13.63bn | ¥13.05bn | ¥11.77bn | ¥8.56bn |
| Shareholders' equity | ¥13.98bn | ¥13.11bn | ¥12.03bn | ¥11.03bn | ¥10.45bn | ¥9.85bn | ¥9.43bn | ¥8.74bn | ¥7.88bn | ¥7.08bn |
| Shares outstanding | 17m | 18m | 18m | 18m | 18m | 18m | 18m | 18m | 18m | 18m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥6.26bn | ¥2.44bn | ¥1.44bn | ¥1.27bn | ¥1.63bn | ¥1.58bn | −¥495.3m | −¥376.4m | −¥912.0m | −¥6.1m |
| Capital spending | −¥48.1m | −¥1.00bn | −¥619.2m | −¥426.2m | −¥285.5m | −¥380.6m | −¥264.5m | −¥235.9m | −¥796.7m | −¥232.3m |
| Free cash flow | ¥6.21bn | ¥1.44bn | ¥823.6m | ¥846.1m | ¥1.34bn | ¥1.20bn | −¥759.8m | −¥612.3m | −¥1.71bn | −¥238.4m |
| Dividends paid | −¥580.9m | −¥545.5m | −¥494.3m | −¥503.5m | −¥503.0m | −¥502.9m | −¥502.5m | −¥394.1m | −¥314.4m | −¥403.9m |
Latest quarters
By quarter end
| Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥5.19bn | ¥8.25bn | ¥9.40bn | ¥4.61bn | ¥4.79bn | ¥8.17bn | ¥5.29bn | ¥4.36bn |
| Gross profit | ¥1.37bn | ¥3.18bn | ¥1.60bn | ¥1.22bn | ¥1.28bn | ¥3.18bn | ¥1.40bn | ¥1.10bn |
| Operating income | ¥316.7m | ¥1.85bn | ¥588.8m | ¥218.3m | ¥286.0m | ¥1.93bn | ¥355.7m | ¥105.0m |
| Net income | ¥207.1m | ¥1.23bn | ¥372.8m | ¥117.9m | ¥175.0m | ¥1.26bn | ¥222.6m | ¥46.0m |
| Diluted earnings per share | 12.09 | 71.67 | 21.77 | 6.69 | 9.93 | 71.22 | 12.63 | 2.61 |
| Cash from operations | — | ¥6.26bn | — | — | — | — | — | — |
| Capital spending | — | −¥48.0m | — | — | — | — | — | — |
| Free cash flow | — | ¥6.21bn | — | — | — | — | — | — |
| Total assets | ¥27.22bn | ¥28.14bn | ¥31.14bn | ¥31.01bn | ¥30.11bn | ¥30.89bn | ¥30.56bn | ¥28.81bn |
| Cash and short-term investments | ¥8.23bn | ¥9.20bn | ¥11.20bn | ¥7.83bn | ¥7.76bn | ¥8.30bn | ¥6.60bn | ¥5.80bn |
| Debt | ¥2.41bn | ¥8.95bn | ¥7.72bn | ¥13.17bn | ¥3.91bn | ¥12.92bn | ¥3.95bn | ¥12.89bn |
| Shareholders' equity | ¥13.71bn | ¥13.98bn | ¥12.90bn | ¥13.03bn | ¥12.90bn | ¥13.11bn | ¥11.84bn | ¥11.77bn |
Financial ratios
Data as of 29 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 26.9% | 30.5% | 30.6% | 28.2% | 28.2% | 29.1% |
| Operating margin | 10.9% | 11.3% | 11.0% | 10.3% | 9.4% | 8.8% |
| Net margin | 7.0% | 7.2% | 7.1% | 6.5% | 5.9% | 5.6% |
| Return on equity | 13.5% | 12.2% | 12.3% | 12.5% | 10.6% | 9.7% |
| Return on assets | 6.7% | 5.2% | 5.1% | 5.1% | 4.2% | 3.8% |
| Free cash flow yield | 41.4% | 22.4% | 13.4% | 11.0% | 12.2% | 12.5% |
| Revenue growth | 21.6% | 7.1% | -2.2% | 12.5% | 11.0% | -5.3% |
| Earnings growth | 18.4% | 7.8% | 7.4% | 24.9% | 16.1% | -20.6% |
| Current ratio | 2.90x | 4.23x | 3.12x | 3.40x | 3.21x | 4.99x |
| Debt to equity | 0.64x | 0.99x | 1.02x | 1.05x | 1.12x | 1.19x |
| Equity ratio | 49.7% | 42.4% | 41.8% | 40.5% | 39.4% | 39.0% |
| Interest coverage | 17.35x | 14.07x | 18.78x | 19.20x | 14.33x | 11.72x |
| Buybacks as a share of market value | 1.1% | 0.0% | 0.0% | 2.1% | -0.0% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.4% | 9.7% | 7.1% |
| Operating income | 12.2% | 14.4% | 6.9% |
| Net income | 11.1% | 14.7% | 7.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 28.5% | 28.9% | 28.9% | 30.4% |
| Operating margin | 11.1% | 10.8% | 10.3% | 10.7% |
| Net margin | 7.1% | 7.0% | 6.6% | 6.7% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 7.8 | 9.1 | 8.5 | 9.4 | 11.2 | 13.5 | 10.6 | 13.2 | 11.3 | 16.3 |
| Price to sales | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.8 | 0.7 | 0.9 | 0.7 | 1.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 26 years. Last went ex-dividend on 27 Nov 2025.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 10.00 | 54.00 | 28.00 | 28.00 | 28.00 | 28.00 | 25.00 | 19.00 |
- 2-for-1 split · 29 May 2017
- 2-for-1 split · 26 May 2004
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.